TY  - JOUR
T1  - PRotective gene for malaria?
AU  - Friedrich MJ
Y1  - 2012/10/17
N1  - 10.1001/jama.2012.13775
JO  - JAMA
SP  - 1515
EP  - 1515
VL  - 308
IS  - 15
N2  - 
The investigators performed genetic tests for the SAO defect in 1975 children from the Madang area of Papua New Guinea who were enrolled in 3 separate malaria studies: a clinical drug prevention trial with 1121 infants aged 3 to 21 months, a case-control study of 318 children with severe malaria aged 10 years and younger, and a treatment time-to-reinfection study of 206 children aged 5 to 14 years. In the 3 studies, the SAO genetic defect was associated with a reduction in risk of clinical P vivax episodes.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2012.13775
UR  - http://dx.doi.org/10.1001/jama.2012.13775
ER  -